Intravenous immunoglobulin for treatment of necrobiotic xanthogranuloma

Dermatol Ther. 2019 Jan;32(1):e12744. doi: 10.1111/dth.12744. Epub 2018 Nov 8.

Authors

Amrita Goyal¹, Daniel O'Leary², Gregory Vercellotti³, Daniel Miller¹, Philip McGlave³

Affiliations

¹ Department of Dermatology, University of Minnesota, Minneapolis, MN.
² Department of Medicine, University of Minnesota, Minneapolis, MN.
³ Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.

PMID: 30221815
DOI: 10.1111/dth.12744

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Biopsy
Facial Dermatoses / diagnosis
Facial Dermatoses / drug therapy*
Facial Dermatoses / immunology
Female
Humans
Immunoglobulins, Intravenous / administration & dosage*
Necrobiotic Xanthogranuloma / diagnosis
Necrobiotic Xanthogranuloma / drug therapy*
Necrobiotic Xanthogranuloma / immunology
Remission Induction
Skin / drug effects*
Skin / pathology
Treatment Outcome

Substances

Immunoglobulins, Intravenous